Siemens to Showcase Innovative Radiotherapy Solutions at ESTRO 27

SiemensAt this year's ESTRO exhibition on the 14th - 18th September in Göteberg, Sweden, Siemens Healthcare will be showcasing the latest advancements in oncology imaging, treatment and therapy management. The medical devices and IT solutions have been designed to provide technological flexibility now and into the future, ensuring the optimum in patient safety and comfort.

The ARTISTE Solution is Siemens’ innovative linear accelerator that offers a full complement of sophisticated imaging tools to optimise workflow. Featuring a small, 5mm thickness over the full-field, the 160 MLC™ Multileaf Collimator provides targeted treatment to the tumour shape independent of its size. MVision™ Megavoltage (MV) Cone Beam Imaging utilises one beam, one source and one detector to provide excellent target imaging in 2D or 3D. ARTISTE’s 550 TxT™ Treatment Table is designed to ensure accurate patient positioning, providing an efficient and stable platform with the mechanical strength to accommodate even large patients.

Siemens' oncology treatment systems are also complemented by the comprehensive syngo® suite for Oncology, offering integrated workflow solutions for radiation therapy. Providing user-centric workspaces, the syngo suite facilitates workflow in image review, 2D, 3D and 4D patient positioning and radiation delivery. The range includes syngo RT Therapist, a solution for reliable, efficient and secure access to all patient information at one convenient location.

Siemens will also be demonstrating the benefits of its MR, MI and PT Planning consoles as well as the IM-Confident treatment planning system that reduces IMRT treatment time.

For further product information visit www.siemens.co.uk/healthcare.

Related news articles:

About Siemens Healthcare
The Siemens Healthcare Sector is one of the world’s largest suppliers to the healthcare industry. The company is a renowned medical solutions provider with core competence and innovative strength in diagnostic and therapeutic technologies as well as in knowledge engineering, including information technology and system integration. With its laboratory diagnostics acquisitions, Siemens Healthcare is the first integrated healthcare company, bringing together imaging and lab diagnostics, therapy and healthcare information technology solutions, supplemented by consulting and support services. Siemens Healthcare delivers solutions across the entire continuum of care - from prevention and early detection, to diagnosis, therapy and care. Additionally, Siemens Healthcare is the global market leader in innovative hearing instruments. The company employs more than 49,000 people worldwide and operates in 130 countries. In the fiscal year 2007 (Sept. 30), Siemens Healthcare reported sales of €9.85 billion, orders of €10.27 billion, and group profit of €1.32 billion. Further information can be found by visiting http://www.siemens.co.uk/healthcare.

Most Popular Now

Researchers Find Telemedicine may Help R…

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A...

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

AI can Open Up Beds in the ICU

At the height of the COVID-19 pandemic, hospitals frequently ran short of beds in intensive care units. But even earlier, ICUs faced challenges in keeping beds available. With an aging...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

AI Model Predicting Two-Year Risk of Com…

AFib (short for atrial fibrillation), a common heart rhythm disorder in adults, can have disastrous consequences including life-threatening blood clots and stroke if left undetected or untreated. A new study...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...